December 2022 - Renal - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal Pathology.
Learn more about how direct ethanol biomarker testing at Mayo Clinic Laboratories provides heightened sensitivity and specificity to accurately assess alcohol use and alcohol use disorder.
Next-generation sequencing - Insights
Browse our full menu of genetic testing, which provides the highest quality molecular assays available.
Kootenai Health: Recapturing their market through precision coordination - Insights
Prevented from providing testing services to its community members due to a non-compete agreement with a national laboratory, Kootenai Health laboratory leaders deepened their relationship with Mayo Clinic Laboratories, receiving tactical...
An uncommon antibody, a life restored: Jori Pearson - Insights
Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves.
Mayo Clinic Labs @Work: Ona Saras - Insights
As a clinical specialty representative, Ona Saras’ decade-long dedication to patient care and advocacy for cutting-edge testing at Mayo Clinic Laboratories has transformed lives across Northern California and Reno, Nevada. Through personal...
Mayo Clinic Labs @Work: Carrie Lahner - Insights
Carrie began her career at Mayo Clinic in 2006 as the associate director of the Eisenberg Genomics Education Program. In her current role as a genetic counselor, she employs her skills to educate on genetic test offerings and support MCL’s...
Living in the moment: Susan Parrott - Insights
As someone affected by chronic liver disease, Susan Parrott knows how it feels to live in uncertainty. But every few months, the anxiety and doubt that shadow her life fade when Mayo Clinic Laboratories test results confirm her condition is...
An order-entry, clinical decision support tool developed by physicians and scientists at Froedtert and the Medical College of Wisconsin (MCW) for clinicians within the healthcare system who order autoimmune and paraneoplastic antibody...
MCL @Work: Sarah Mason - Insights
In her current role as senior manager for global logistics at Mayo Clinic Laboratories, Sarah Mason oversees the coordination of patient sample shipments by working with a network of stakeholders, couriers, carriers, and vendors. Sarah...
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights
Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...
Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy - Insights
In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and...
MCL @Work: Brian Dukek - Insights
As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline...
Finding the Balance: Legal Issues Arising from Precision Medicine - Insights
By taking into account an individual’s genes, lifestyle, and environment, precision medicine offers the prospect of finding individualized therapies that might ultimately cure diseases such as cancer and diabetes. Yet, as with other...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Jeff Meeusen, Ph.D., Provides Clinical Update on Ceramides - Insights
Jeff Meeusen, Ph.D., Co-Director of Cardiovascular Laboratory Medicine in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota, provides a clinical update on ceramides.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
STAT testing is available on a limited basis for patients with a suspected or known inborn error of metabolism when there is an increased risk of illness or death due to metabolic decompensation or when testing will allow for emergent...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
UofL Health – UofL Hospital physicians and laboratory scientists faced challenges in the ordering of autoimmune and paraneoplastic panels: duplicate orders that add unnecessary cost and omitted test orders that could provide the key to the...
MCL @Work: Robin Huiras-Carlson - Insights
Robin Huiras-Carlson's connection with Mayo Clinic traces back to her early years, marked by a diagnosis of a rare genetic condition at the age of 10. Today, as a senior marketing specialist with Mayo Clinic Laboratories, she draws...
MCL @Work: Jane Hermansen - Insights
Outreach manager Jane Hermansen regards Mayo Clinic as the pinnacle of healthcare. Having spent her formative years in Minnesota, she was inspired by her uncle Roger to embark on a path as a laboratory scientist. Presently, she oversees the...
April 2023 - Ophthalmic Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Ophthalmic Pathology.
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
Ingenuity, collaboration, and expertise create a game-changing COVID-19 test swab - Insights
A massive effort culminated in Mayo Clinic designing, testing and mass-manufacturing a 3D-printed mid-turbinate swab for COVID-19 testing.
Epansive clinical test menu, including more than 3,500 CAP- and CLIA-accredited tests. In addition to offering the world’s most sophisticated specialty test menu, we provide access to research-grade tests, pathology services, and sponsored...
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...
Cytomegalovirus, or CMV, is a common cause of disease in the transplant population. In some patients who are diagnosed with CMV and are on antiviral treatment for infections, the virus may develop resistance to the drugs. This “Hot Topic”...
Global capabilities - Insights
Check out how Mayo Clinic Laboratories optimized global capabilities facilitate individualized solutions that ensure international clients receive expeditious, accurate answers.
The birth of Mayo Clinic Laboratories: From tiny operation to international mainstay - Insights
In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and...
CPT Codes and LOINC Update: September 2020 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of September
Sorting through the Details of an Automation Solution - Insights
Laboratories face increasing pressure to automate their operations as they are challenged by a continuing increase in workload, a need to reduce expenditure, and a demand for accuracy and improved turnaround time—essentially doing more with...
October 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
March 2023 - Hematopathology & Laboratory Genetics and Genomics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case's sub-specialties are Hematopathology and Laboratory Genetics and Genomics.
August 2023 - Lab Genetics & Genomics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Laboratory Genetics and Genomics.
Progressive alliance advances science through patient-powered research - Insights
Tying together the expertise and curiosity of Mayo Clinic autoimmune neurology researchers with eager patients who have rare disease and are looking for answers, the innovative collaboration benefits both patients affected by MOGAD and...
Mayo Clinic Laboratories’ full suite of pediatric hematologic testing equips pediatric hematologists with comprehensive answers to diagnose and direct care.
In this month’s “Hot Topic,” Robin Patel, M.D., discusses the FilmArray meningitis/encephalitis (ME) panel, describing the panel, her experience with it, and an algorithm for its use.
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...
Mayo Clinic Laboratories is one of the few laboratories in the country to offer two special sequencing-based tests for bacteria in its catalog. The first test is designed to help protect patients by investigating potential outbreaks of a...
CPT codes and LOINC update: May 2023 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of May.
High-Resolution Targeted Benzodiazepine Screen - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic’s targeted benzodiazepine assay and discusses the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine...
QuantiFERON-TB Gold Plus - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D. will discuss a new interferon-gamma release assay that can assist in the detection of individuals that are infected with tuberculosis.
Phlebotomy Top Gun: Drawing Blood from a Patient Receiving Intravenous Fluids - Insights
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., presents a case-based scenario on drawing blood from a patient receiving intravenous fluids.
Personal journey shapes unique perspective: Linda Hasadsri, M.D., Ph.D. - Insights
Dr. Linda Hasadsri’s firsthand encounter with the genetic tests she’s helped develop has provided rare insight into testing quality and implications, enhancing their ability to advocate for the value of testing and infusing their work with...
Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.
Defying all odds and exploring a remarkable journey beyond diagnosis: Mike Knudson - Insights
In August of 2021, 28-year-old Mike Knudson, a Twin Cities resident known for his vibrant and active lifestyle, set out on what he anticipated to be an adventurous hiking vacation to the picturesque Glacier National Park in Montana. Little...